5 billion in cash.

The transaction also includes payments of up to EUR 300 million if certain product sales milestones are fulfilled between 2011 and 2013. Abbott plans to invest in the transaction with money on the total amount sheet currently. This transaction is at the mercy of customary closing circumstances and regulatory approvals and is certainly expected to close in the first quarter of 2010. As a total result, the deal shall haven’t any impact on 2009 ongoing earnings per share. The boards of directors of both companies have accepted the proposed acquisition. Barclays Capital served as a special monetary advisor to Abbott on this transaction. Abbott Conference Contact Abbott will conduct a special conference contact today at 7 a.m.There’s a solution to the madness. Don’t Eat CancerYou don’t need more chemicals in your body, you need to remove more, if not all, from your body. If you want energy, intelligence and immunity, stop eating pesticide, insecticide, herbicide and fungicide. Filtration system them all from your daily intake. Did you know that animal stress outcomes in meat that triggers disease? There are convenient ways to filter toxins from your daily intake.